Mitochondria and Neurodegeneration
The DOI matches its Crossref record.
Abstract
There is increasing evidence linking mitochondrial dysfunction to neurodegenerative diseases. Mitochondria are critical regulators of cell death, a key feature of neurodegeneration. Mutations in mitochondrial DNA and oxidative stress both contribute to ageing, which is the greatest risk factor for neurodegenerative diseases. This is the case in Alzheimer's disease, in which there is evidence that both beta-amyloid and the amyloid precursor protein may directly interact with mitochondria, leading to increased free radical production. In the case of Huntington's disease (HD), recent evidence suggests that the coactivator PGC1alpha, a key regulator of mitochondrial biogenesis in respiration, is down-regulated in patients with HD and in several animal models of this neurodegenerative disorder. In Parkinson's disease, the autosomal recessive genes parkin, DJ1 and PINK1 are all linked to either oxidative stress or mitochondrial dysfunction. In amyotrophic lateral sclerosis, there is strong evidence that mutant superoxide dismutase directly interacts with the outer mitochondrial membrane as well as the intermembrane space and matrix. Therefore, an impressive number of disease specific proteins interact with mitochondria. Therapies that target basic mitochondrial processes such as energy metabolism in free radical generation, or specific interactions of disease-related protein with mitochondria, hold great promise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940
“Previous studies have suggested that mitochondrial dysfunction plays a central role in the pathogenesis of neurodegenerative disorders, including Alzheimer’s disease (AD) (1, 4).”
BackgroundGlial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration
Liu, L., Zhang, K., Sandoval, H., Yamamoto, S., Jaiswal, M., Sanz, E., Li, Z., Hui, J., Graham, B. H., Quintana, A., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.019 · Cited by 876
“Complexes I and III of the mitochondrial electron transport chain are the major contributors of free radicals and ROS (Beal, 2007).”
Mitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
“…tron transport chain NADH dehydrogenase (complex I) activity was first found in the substantia nigra of patients with PD, followed by studies identifying a similar complex I deficit in platelets, lymphocytes, and, less consistently, in muscle tissue from patients with PD (reviewed in Beal, 2007).”
BackgroundSelf-citationMitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 783
Self-citation
Metadata
- Authors
- Beal, M. F.
- Venue
- Novartis Foundation Symposia
- Publisher
- Wiley
- Published
- 2007-10-05
- Volume
- 287
- Pages
- 183-196
- ISSN
- 1528-2511 (ISSN-L)
- 1935-4657
- OpenAlex
- W2115901104
- Cited by
- 97
- References
- 0
- Type
- other
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitochondria and Neurodegeneration. https://app.cochat.ai/papers/10.1002/9780470725207.ch13
- The paper
- Beal, M. F. (2007). Mitochondria and Neurodegeneration. Novartis Foundation Symposia. https://doi.org/10.1002/9780470725207.ch13
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.